MARKET

IDRSF

IDRSF

Idorsia
EXMKT
3.950
NaN%
Closed 09:30 02/12 EST
OPEN
--
PREV CLOSE
3.950
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
4.580
52 WEEK LOW
1.500
MARKET CAP
919.71M
P/E (TTM)
-4.7654
1D
5D
1M
3M
1Y
5Y
1D
Idorsia: FDA-Aligned Phase 3 Pathway and Broad Fabry Disease Positioning Support Buy Rating and CHF6 Target
TipRanks · 4d ago
Idorsia Ltd (IDIA) Receives a Buy from Kepler Capital
TipRanks · 01/30 12:06
Idorsia: Latin America QUVIVIQ Deal and Pipeline Optionality De‑Risk Path to Profitability, Supporting Reiterated Buy Rating
TipRanks · 01/29 11:35
Idorsia: Differentiated Insomnia and Hypertension Assets, Understated Guidance, and Pipeline Upside Support Reiterated Buy Rating
TipRanks · 01/20 11:38
Idorsia Advances Fabry Disease Program With Encouraging Phase 3 Results
NASDAQ · 01/12 07:29
Idorsia: Cardiovascular Franchise Momentum and Underappreciated Pipeline Drive Buy Rating and Valuation Upside
TipRanks · 01/05 11:25
Buy Rating for Idorsia Driven by Promising Aprocitentan Trial Results and Market Potential
TipRanks · 12/11/2025 11:16
Idorsia upgraded to Buy from Hold at Kepler Cheuvreux
TipRanks · 12/01/2025 10:15
More
About IDRSF
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

Webull offers Idorsia Ltd stock information, including EXMKT: IDRSF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDRSF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IDRSF stock methods without spending real money on the virtual paper trading platform.